iRhythm Holdings, Inc. IRTC
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-10-20
iRhythm Holdings, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 70.6% | 68.9% | 67.3% | 68.5% | 66.2% |
| Operating margin | -7.7% | -19.5% | -25.4% | -27.7% | -31.0% |
| Net margin | -6.0% | -19.1% | -25.0% | -28.3% | -31.4% |
| FCF margin | 4.6% | -5.2% | -18.4% | -12.9% | -20.4% |
| Return on assets | -4.4% | -12.2% | -28.5% | -25.9% | -21.9% |
| Return on equity | -29.2% | -124.6% | -58.7% | -48.4% | -36.3% |
| Debt / equity | — | — | 0.17× | 0.15× | 0.03× |
| Current ratio | 4.63 | 5.82 | 2.15 | 3.24 | 3.48 |
| Revenue growth | 26.2% | 20.1% | 19.9% | 27.3% | 21.7% |
Source: SEC EDGAR filings · CIK 0001388658 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.